MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters
Study Title: Brain Transmitters/Metabolites, Magnetic Resonance Spectroscopy, and Brain Connectivity: Diagnostic Strategies to Study the Effects of Non-Pharmacologic Therapies for Dysautonomia and Chronic Nausea
Sponsor: Wake Forest University Health Sciences
This observational or N/A phase trial investigates Dysautonomia and is currently completed. Wake Forest University Health Sciences leads this study, which shows 8 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2017 — May 2017 [monthly]
Unknown Status NA
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .